We are live on ! Find out more
DNLI icon

Denali Therapeutics
DNLI

188 hedge funds and large institutions have $2.73B invested in Denali Therapeutics in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 72 increasing their positions, 58 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

224% more call options, than puts

Call options by funds: $1.82M | Put options by funds: $561K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

24% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 58

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

4.75% more ownership

Funds ownership: 70.64% → 75.39% (+4.7%)

3% less capital invested

Capital invested by funds: $2.8B → $2.73B (-$71.3M)

1% less funds holding

Funds holding: 190 → 188 (-2)

Holders
188
Holders Change
-2
Holders Change %
-1.05%
% of All Funds
3.17%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
21
Increased
72
Reduced
58
Closed
19
Calls
$1.82M
Puts
$561K
Net Calls
+$1.25M
Net Calls Change
+$2.24M

Top Buyers

1
AVM
Arch Venture Management
Illinois
+$135M
2
Marshall Wace
Marshall Wace
United Kingdom
+$17.4M
3
Millennium Management
Millennium Management
New York
+$16.9M
4
BlackRock
BlackRock
New York
+$15.7M
5
BBA
Baker Bros. Advisors
New York
+$13.1M

Top Sellers

1
GGHC
Gilder Gagnon Howe & Co
New York
-$17.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$11.7M
3
BAMCO Inc
BAMCO Inc
New York
-$9.94M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.21M
5
Morgan Stanley
Morgan Stanley
New York
-$7.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
76
Putnam Investments
Massachusetts
$1.89M +$8.72K +333 +0.5%
ECM
77
ExodusPoint Capital Management
New York
$1.89M +$1.68M +64,187 New
GC
78
Guggenheim Capital
Illinois
$1.79M +$172K +6,580 +12%
DekaBank Deutsche Girozentrale
79
DekaBank Deutsche Girozentrale
Germany
$1.71M – – –
CAM
80
ClariVest Asset Management
California
$1.61M -$288K -11,000 -17%
PIM
81
Platinum Investment Management
Australia
$1.5M – – –
MIM
82
MetLife Investment Management
New Jersey
$1.48M – – –
Voloridge Investment Management
83
Voloridge Investment Management
Florida
$1.41M +$279K +10,669 +29%
AIG
84
American International Group
New York
$1.36M +$24.8K +945 +2%
Los Angeles Capital Management
85
Los Angeles Capital Management
California
$1.29M +$43.7K +1,667 +4%
SG Americas Securities
86
SG Americas Securities
New York
$1.16M +$795K +30,336 +338%
AG
87
AIA Group
Hong Kong
$1.09M -$113K -4,321 -10%
PP
88
PDT Partners
New York
$1.07M +$484K +18,491 +104%
Mirae Asset Global Investments
89
Mirae Asset Global Investments
South Korea
$1.04M +$923K +35,234 New
SO
90
STRS Ohio
Ohio
$991K +$73.3K +2,800 +9%
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$950K +$47.7K +1,820 +6%
Envestnet Asset Management
92
Envestnet Asset Management
Illinois
$896K -$76.4K -2,915 -9%
CGL
93
Clarius Group LLC
Washington
$839K +$54.3K +2,074 +8%
CWM
94
Concentric Wealth Management
California
$823K – – –
EAM
95
Erste Asset Management
Austria
$780K – – –
Mercer Global Advisors
96
Mercer Global Advisors
Colorado
$702K +$24.8K +948 +4%
HF
97
HRT Financial
New York
$694K +$618K +23,600 New
ASRS
98
Arizona State Retirement System
Arizona
$682K +$44.8K +1,709 +8%
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$657K +$369K +14,089 +171%
ProShare Advisors
100
ProShare Advisors
Maryland
$653K -$254K -9,707 -30%
2 3
4
5 6

DNLI Hedge Fund Activity: Q2 2022 in Review

188 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Denali Therapeutics (DNLI) for Q2 2022, worth a combined $2.73B — down 2.5% from $2.8B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DNLI positions and 19 closed out — a net gain of 2 holders — while 72 added to existing stakes and 58 trimmed.

The largest buyer was Arch Venture Management, opening a new position worth an estimated $135M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $17.4M.

  • 188 institutional investors held Denali Therapeutics (DNLI) as of Q2 2022, down from 190 in Q1 2022.
  • Funds reported $2.73B of Denali Therapeutics stock for Q2 2022, down 2.5% quarter-over-quarter.
  • 21 funds opened new Denali Therapeutics positions in Q2 2022 and 19 closed out, a net change of +2 holders.
  • The largest Denali Therapeutics buyer in Q2 2022 was Arch Venture Management, an estimated $135M added.
  • The largest Denali Therapeutics seller in Q2 2022 was Gilder Gagnon Howe & Co, an estimated $17.4M sold.

Based on aggregated 13F filings for Q2 2022.